Skip to main content
Journal of Clinical Laboratory Analysis logoLink to Journal of Clinical Laboratory Analysis
. 2008 Mar 17;22(2):114–118. doi: 10.1002/jcla.20227

Prediction of diagnosis of immunoglobulin a nephropathy prior to renal biopsy and correlation with urinary sediment findings and prognostic grading

Kazutaka Nakayama 1, Isao Ohsawa 1, Atsuko Maeda‐Ohtani 1, Maki Murakoshi 1, Satoshi Horikoshi 1, Yasuhiko Tomino 1,
PMCID: PMC6649041  PMID: 18348316

Abstract

Several clinical markers correlate well with the diagnosis and prognosis of IgA nephropathy (IgAN). In the present study, we re‐evaluated the usefulness of these four clinical markers for prediction of the diagnosis of patients with IgAN through a comparison between many more patients with IgAN and those with other types of renal diseases. 364 patients with IgAN and 289 with other types of renal disease were examined. An analysis was performed prior to renal biopsy, using clinical markers including, serum IgA, serum IgA/C3 ratio, number of red blood cells in urinary sediments, and urinary protein. Patients with IgAN were divided into four groups according to histopathological findings. Presence of microscopic hematuria, persistent proteinuria, high serum IgA levels, and the serum IgA/C3 ratios are useful for prediction of diagnosis of IgAN and distinguishing it from other renal diseases. Blood pressure, urinary protein, serum uric acid, renal function, and urinary sediment findings may be useful for prediction of prognostic grading in patients with IgAN. J. Clin. Lab. Anal. 22:114–118, 2008. © 2008 Wiley‐Liss, Inc.

Keywords: IgA nephropathy, IgA/C3 ratio, urinary sediment, urinary cast

REFERENCES

  • 1. D'Amico G. Clinical features and natural history in adults with IgA nephropathy. Am J Kidney Dis 1988;12:353–357. [DOI] [PubMed] [Google Scholar]
  • 2. Tomino Y, Suzuki S, Imai H, et al. Measurement of serum IgA and C3 may predict the diagnosis of patients with IgA nephropathy prior to renal biopsy. J Clin Lab Anal 2000;14:220–223. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3. Komatsu H, Fujimoto S, Hara S, Sato Y, Yamada K, Eto T. Relationship between the serum IgA/C3 ratio and the progression of IgA nephropathy. Intern Med 2004;43:1023–1028. [DOI] [PubMed] [Google Scholar]
  • 4. Ishiguro C, Yaguchi Y, Funabiki K, Horikoshi S, Shirato I, Tomino Y. Serum IgA/C3 ratio may predict diagnosis and prognosis grading in patients with IgA nephropathy. Nephron 2002;91:755–758. [DOI] [PubMed] [Google Scholar]
  • 5. Maeda A, Gohda T, Funabiki K, Horikoshi S, Shirato I, Tomino Y. Significance of serum IgA levels and serum IgA/C3 ratio in diagnostic analysis of patients with IgA nephropathy. J Clin Lab Anal 2003;17:73–76. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6. D'Amico G. Natural history of idiopathic IgA nephropathy: role of clinical and histological prognostic factors. Am J Kidney Dis 2000;36:227–237. [DOI] [PubMed] [Google Scholar]
  • 7. Tomino Y, Sakai H, Special Study Group (IgA Nephropathy) on Progressive Glomerular Disease . Clinical guideline for immunoglobulin A (IgA) nephropathy in Japan, Second Version. Clin Exp Nephrol 2003;72:93–97. [DOI] [PubMed] [Google Scholar]
  • 8. Imai N, Orita Y, Tanaka Y, Konobe K, Amino N, Miyai K. [Clinical findings of urinary sediment dysmorphic red blood cells and casts in renal disease]. Rinsho Byori 1992;40:720–727. [Japanese] [PubMed] [Google Scholar]
  • 9. Fuiano G, Mazza G, Comi N, et al. Current indications for renal biopsy: a questionnaire‐based survey. Am J Kidney Dis 2000;35:448–457. [DOI] [PubMed] [Google Scholar]
  • 10. Bartosik LP, Lajoie G, Sugar L, Cattran DC. Predicting progression in IgA nephropathy. Am J Kidney Dis 2001;38:728–735. [DOI] [PubMed] [Google Scholar]
  • 11. Rauta V, Finne P, Fagerudd J, Rosenlof K, Tornroth T, Gronhagen‐Riska C. Factors associated with progression of IgA nephropathy are related to renal function—a model for estimating risk of progression in mild disease. Clin Nephrol 2002;58:85–94. [DOI] [PubMed] [Google Scholar]
  • 12. Szeto CC, Lai FM, To KF, et al. The natural history of immunoglobulin A nephropathy among patients with hematuria and minimal proteinuria. Am J Med 2001;110:434–437. [DOI] [PubMed] [Google Scholar]
  • 13. Ohno I, Hosoya T, Gomi H, Ichida K, Okabe H, Hikita M. Serum uric acid and renal prognosis in patients with IgA nephropathy. Nephron 2001;87:333–339. [DOI] [PubMed] [Google Scholar]
  • 14. Daniel L, Sainga Y, Giorgi R, Bouvier C, Pellissier JF, Berland Y. Tubular lesions determine prognosis of IgA nephropathy. Am J Kidney Dis 2000;35:13–20. [DOI] [PubMed] [Google Scholar]
  • 15. Mera J, Uchida S, Nagase M. Clinicopathologic study on prognostic markers in IgA nephropathy. Nephron 2000;84:148–157. [DOI] [PubMed] [Google Scholar]
  • 16. Fogazzi GB, Grignani S, Colucci P. Urinary microscopy as seen by nephrologists. Clin Chem Lab Med 1998;36:919–924. [DOI] [PubMed] [Google Scholar]
  • 17. Vikse BE, Bostad L, Aasarød K, Lysebo DE, Iversen BM. Prognostic factors in mesangioproliferative glomerulonephritis. Nephrol Dial Transplant 2002;17:1603–1613. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Clinical Laboratory Analysis are provided here courtesy of Wiley

RESOURCES